Description
Translational Studies of RyR2 Modulation for Human Ventricular Fibrillation
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #02015-07-01$625,834
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2015-07-01(start date) | $625,834 | — | Translational Studies of RyR2 Modulation for Human Ventricular Fibrillation |
Related records · 4
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (exact legal name match; no business number on file)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 236-2025-2026-Q3-00729 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research | $654,076 | FY2026 |
| 236-2023-2024-Q3-00240 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research | $100,000 | FY2024 |
| 236-2022-2023-Q3-00121 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research | $495,720 | FY2023 |
| 236-2017-2018-Q1-00461 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $600,524 | FY2018 |
Cite as: Glassbox record view · Federal grants & contributions · 236-2015-2016-Q2-00111 · retrieved 2026-11-14.